Previous close | 325.00 |
Open | 330.00 |
Bid | 320.00 x 0 |
Ask | 340.00 x 0 |
Day's range | 320.20 - 338.00 |
52-week range | 180.00 - 430.00 |
Volume | |
Avg. volume | 23,314 |
Market cap | 344.995M |
Beta (5Y monthly) | 1.08 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.28 |
Earnings date | 07 Aug 2024 - 12 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 5.51 |
Investors who take an interest in MaxCyte, Inc. ( LON:MXCT ) should definitely note that the President, Maher Masoud...
The average of price targets set by Wall Street analysts indicates a potential upside of 85% in MaxCyte (MXCT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
MaxCyte (MXCT) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.